NICXF:OTCMKTS
NicOx SA
$0.30
0.00%
(0.00) 1D
Jul 17, 9:30:01 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NICXF...
Mkt. cap
26.19M
Volume
0.00
52-wk high
$0.30
52-wk low
$0.30
Shares outstanding
81.24M
No. of employees
10
Mkt. cap
26.19M
Volume
0.00
52-wk high
$0.30
52-wk low
$0.30
Shares outstanding
81.24M
No. of employees
10
News stories
From web sources and news partners
Devdiscourse
·
23 minutes ago
US STOCKS-Dow outperforms as Wall Street rises, healthcare stocks lead gains
marketscreener.com
·
2 minutes ago
US Equity Indexes Mixed as Weakness in Communications Services, Technology Restrains Nasdaq Composite
TradingView
·
1 hour ago
The Dow Jones Index Closes 1.02% Higher
Insider Monkey
·
4 hours ago
Ciena (CIEN): Is the AI-Optical Boom Enough to Carry It Into the S&P 500?
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, France
SectorBiotechnology
Websitenicox.com